When will Bendamustine Hydrochloride Injection, Solution be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Bendamustine Hydrochloride Injection, Solution changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Bendamustine Hydrochloride Injection, Solution

Category: Oncology

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Jul 23, 2026 · First posted: Jul 23, 2026 · 1 manufacturers, 1 listed presentations

As of Jul 23, 2026, the FDA lists Bendamustine Hydrochloride Injection, Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Bendamustine Hydrochloride Injection, Solution is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08) NDC 63459-390-08	Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)	Not specified	A business decision has been made to discontinue manufacture of the drug.

Related medications in shortage

Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Bendamustine Hydrochloride Injection, Solution (FDA data as of Jul 23, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Bendamustine Hydrochloride Injection, Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Bendamustine Hydrochloride Injection, Solution.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/bendamustine-hydrochloride-injection-solution.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).